March 23, 2026

Researchers Propose TMD Definition for GBD

Consensus description may support inclusion in Global Burden of Disease estimates.

Conexiant

March 23, 2026

Collagen Linked to Skin, Joint Benefits

A large umbrella review of randomized trials found the strongest evidence for improvements in skin elasticity and osteoarthritis symptoms.

Conexiant

March 17, 2026

Toward Smarter Diagnosis of Prosthetic Joint Infection

Artificial intelligence models show promise but face key validation and design limitations

Conexiant

March 17, 2026

Obesity Medications Get New Guidance

Panel outlines pharmacotherapy roles across obesity complications and long-term weight management.

Conexiant

March 17, 2026

Comorbidities Worsen Carpal Tunnel Outcomes

Patients with systemic diseases had worse symptoms and function before and following surgery, though improvement after release was similar.

Conexiant

March 16, 2026

Knee OA Trial Tests Diacerein

Researchers compared diacerein and placebo in a 24-week randomized study involving knee osteoarthritis with MRI-confirmed effusion-synovitis.

Conexiant

March 11, 2026

Collagenase Effective for Recurrent Dupuytren

Collagenase treatment improves contracture recurrence in patients after prior surgery

Conexiant

March 05, 2026

Orthopedic Residency: Weighing a Move

Investigators outline motivations, regulatory requirements, and transition strategies for residents seeking to change orthopedic training programs.

Conexiant

March 04, 2026

Exercise in Osteoarthritis: Does It Help?

Overview data on exercise therapy in osteoarthritis question its universal promotion

Conexiant

March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant